Nine Chapters Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,100
Closed -$307K 240
2016
Q4
$307K Buy
+2,100
New +$316K 0.52% 75
2015
Q4
Sell
-28,300
Closed -$3.91M 32
2015
Q3
$3.91M Buy
28,300
+25,000
+758% +$3.94M 0.34% 50
2015
Q2
$507K Buy
+3,300
New +$529K 0.04% 570
2014
Q2
Sell
-14,000
Closed -$1.73M 929
2014
Q1
$1.73M Buy
+14,000
New +$1.7M 0.2% 131
2013
Q3
Sell
-7,000
Closed -$691K 743
2013
Q2
$691K Buy
+7,000
New +$726K 0.12% 264

Other funds holding AMGN

Nine Chapters Capital Management's AMGN Position: Q1 2017 in Review

Nine Chapters Capital Management sold out of Amgen (AMGN) in Q1 2017, closing a stake of 2,100 shares — an estimated $307K sold.

Nine Chapters Capital Management first reported a position in AMGN in Q2 2013 and held it in 5 quarters. The position peaked at $3.91M in Q3 2015. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Nine Chapters Capital Management reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 2,100 Amgen shares in Q1 2017, an estimated $307K.
  • Nine Chapters Capital Management first reported a position in Amgen in Q2 2013 and held it in 5 quarters.
  • Nine Chapters Capital Management's Amgen position peaked at $3.91M in Q3 2015.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Nine Chapters Capital Management's 13F filing for Q1 2017, filed 8 May 2017.